MedPath

Effect of supplementation in treatment of cervical intraepithelial neoplasia 1

Phase 2
Conditions
Cervical intraepithelial neoplasia 1(CIN1).
Cervix uteri, unspecified
C53.9
Registration Number
IRCT201403155623N17
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
58
Inclusion Criteria

Women aged 18-55 years
Diagnosed with cervical intraepithelial neoplasia 1

Exclusion Criteria

Women who had a history of cervical cancer or other cancers of the lower genital tract
History of hysterectomy or destructive therapy of the cervix
Pregnant women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cervical intraepithelial neoplasia grade. Timepoint: Baseline and End-of-trial. Method of measurement: Colposcopy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath